Volume 68, Issue 6, Pages (December 2015)

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 2009)
Advertisements

Volume 72, Issue 1, Pages (July 2017)
Volume 68, Issue 2, Pages (August 2015)
Volume 62, Issue 1, Pages (July 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Volume 61, Issue 6, Pages (June 2012)
Volume 70, Issue 6, Pages (December 2016)
Volume 62, Issue 5, Pages (November 2012)
Volume 64, Issue 6, Pages (December 2013)
Volume 54, Issue 6, Pages (December 2008)
Volume 73, Issue 6, Pages (June 2018)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Volume 51, Issue 4, Pages (April 2007)
Volume 73, Issue 1, Pages (January 2018)
Volume 71, Issue 5, Pages (May 2017)
Prostate Cancer Epidemic in Sight?
Volume 63, Issue 4, Pages e53-e56 (April 2013)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 5, Pages (November 2015)
Volume 54, Issue 4, Pages (October 2008)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Volume 67, Issue 3, Pages (March 2015)
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 69, Issue 3, Pages (March 2016)
Volume 62, Issue 1, Pages (July 2012)
Counselling the Prostate Cancer Patient
Volume 73, Issue 4, Pages (April 2018)
Volume 66, Issue 6, Pages (December 2014)
Prostate Cancer Epidemic in Sight?
Global Burden of Urologic Cancers, 1990–2013
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 61, Issue 2, Pages (February 2012)
Volume 62, Issue 4, Pages (October 2012)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 68, Issue 6, Pages e134-e135 (December 2015)
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
Volume 58, Issue 3, Pages (September 2010)
Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Volume 72, Issue 4, Pages (October 2017)
Volume 74, Issue 6, Pages (December 2018)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Volume 74, Issue 4, Pages (October 2018)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Volume 74, Issue 5, Pages (November 2018)
Volume 59, Issue 4, Pages (April 2011)
Volume 75, Issue 3, Pages (March 2019)
Volume 72, Issue 1, Pages (July 2017)
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Thomas Steuber, Matthew Frank O'Brien, Hans Lilja  European Urology 
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Volume 74, Issue 6, Pages (December 2018)
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Volume 53, Issue 5, Pages (May 2008)
Volume 68, Issue 2, Pages (August 2015)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Presentation transcript:

Volume 68, Issue 6, Pages 1076-1082 (December 2015) Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death  Axel Gerdtsson, Jessica B. Poon, Daniel L. Thorek, Lorelei A. Mucci, Michael J. Evans, Peter Scardino, Per-Anders Abrahamsson, Peter Nilsson, Jonas Manjer, Anders Bjartell, Johan Malm, Andrew Vickers, Stephen J. Freedland, Hans Lilja, David Ulmert  European Urology  Volume 68, Issue 6, Pages 1076-1082 (December 2015) DOI: 10.1016/j.eururo.2015.03.017 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Selection of cases and controls. MDCS=Malmö Diet and Cancer Study; MPP=Malmö Preventive Project; PCa=prostate cancer. European Urology 2015 68, 1076-1082DOI: (10.1016/j.eururo.2015.03.017) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 2 Predicted risk of prostate cancer diagnosis at age 68 yr by adolescent weight. European Urology 2015 68, 1076-1082DOI: (10.1016/j.eururo.2015.03.017) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 3 Predicted risk of prostate cancer metastasis at age 70 yr by adult weight. European Urology 2015 68, 1076-1082DOI: (10.1016/j.eururo.2015.03.017) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 4 Predicted risk of prostate cancer metastasis at age 70 yr by adult body mass index. BMI=body mass index. European Urology 2015 68, 1076-1082DOI: (10.1016/j.eururo.2015.03.017) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 5 Predicted risk of death from prostate cancer at age 71 yr by adult weight. European Urology 2015 68, 1076-1082DOI: (10.1016/j.eururo.2015.03.017) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 6 Predicted risk of death from prostate cancer at age 71 yr by adult body mass index. BMI=body mass index. European Urology 2015 68, 1076-1082DOI: (10.1016/j.eururo.2015.03.017) Copyright © 2015 European Association of Urology Terms and Conditions